Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aytu BioScience, Inc.

2.00
+0.510034.23%
Post-market: 2.000.00000.00%19:57 EDT
Volume:8.08M
Turnover:15.42M
Market Cap:12.34M
PE:-2.41
High:2.27
Open:1.54
Low:1.50
Close:1.49
Loading ...

Aytu Biopharma Inc. Announces $14.4 Million Upsized Public Offering of Common Stock

Reuters
·
06 Jun

Aytu BioPharma Inc. Secures Exclusive Agreement to Commercialize EXXUA for MDD Treatment in the U.S

Reuters
·
06 Jun

Aytu Biopharma Inc. Conducted Annual Stockholders Meeting

Reuters
·
22 May

Aytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Aytu Biopharma Reports 32% Increase in Q3 2025 Net Revenue, Achieves $4.0 Million Net Income and Adjusted EBITDA of $3.9 Million

Reuters
·
15 May

Aytu BioPharma Q3 EPS $0.21 Beats $(0.17) Estimate, Sales $18.45M Beat $13.74M Estimate

Benzinga
·
15 May

Aytu Biopharma Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
13 May

Aytu Biopharma Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
10 May

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

ACCESS Newswire
·
22 Apr

Aytu BioPharma’s treatment of Marfan syndrome receives FDA orphan designation

TIPRANKS
·
15 Apr

Aytu BioPharma, Inc. (NASDAQ:AYTU) On The Verge Of Breaking Even

Simply Wall St.
·
08 Apr

Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven

Simply Wall St.
·
15 Feb

Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position and Strategic ...

GuruFocus.com
·
13 Feb

Aytu Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Aytu BioPharma Q2 EPS $(0.28), Inline, Sales $16.22M Beat $15.55M Estimate

Benzinga
·
13 Feb

Aytu Biopharma Q2 Net Income USD 800 Thousand

THOMSON REUTERS
·
13 Feb

Aytu Biopharma Q2 Revenue USD 2.4 Million

THOMSON REUTERS
·
13 Feb

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

ACCESS Newswire
·
13 Feb

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

ACCESS Newswire
·
06 Feb

Aytu Biopharma Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
03 Feb